MICHAEL GREENBAUM: Open Payments
NPI 1598792970 · LIBERTYVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 34 payments from 14 companies in 2025. Trend: 2023 $872 · 2024 $999 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Lundbeck LLC | 3 | $64 |
| Vertical Pharmaceuticals, LLC | 3 | $52 |
| Supernus Pharmaceuticals, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Tris Pharma Inc | 2 | $34 |
| Neos Therapeutics, LP | 1 | $23 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, Relexxii, Qelbree, SPRAVATO, Adzenys XR-ODT.
Industry payments across IL — which companies pay providers there.
